Filter Search


Healthcare and Medical


Location Summary Deadline
Poland Delivery Of Medicinal Products For The Needs Of The Independent Public Health Care Center In Lubartów 2026-08-27
Poland Purchase Of An Angiograph 2026-08-27
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V With The Active Ingredient Eculizumab 2026-08-27
India Pro. & Erecting, Barrcading, Pendal, Shamiyana & Etc. For Shro Ganesh Imm Ersion At Police Line Takli In Pr. No. 10 In Mangalwari Zone No. 10. 2026-08-28
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For Contracts For Biosimilar Active Ingredients 2026-08-28
Germany Conclusion Of Non-exclusive Discount Agreements According To § 130a Para. 8 Sgb V For The Mentioned Active Ingredients With The Possibility Of Conclusion Within The Framework Of The So-called Open House Procedure. 2026-08-28
Germany The Gwq Serviceplus Ag Intends To Conclude Non-exclusive Discount Agreements According To § 130a Abs. 8 Sgb V For The Active Ingredient Abrocitinib-vv89, Starting From 01.04.2026. All Interested Companies Can Join This Contract At Any Time During The Cont 2026-08-28
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Combination Calcipotriol I Betamethasone (enstilar)-vv89 2026-08-28
Germany Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V For The Active Ingredient Combination Formoterol I Glycopyrronium I Budesonide (trixeo)-vv89 2026-08-28
Germany Medicines With The Active Ingredient Combination Oxycodone And Naloxone (atc: N02aa55) 2026-08-29
Whats app